News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • OECD says heavy AI infrastructure investment lifts 2026 growth slightly above prior projections.
  • OECD warns a Middle East-driven commodity shock will constrain 2027 momentum and push inflation higher.
  • IonQ shares jumped after demonstrating an end-to-end real-time quantum error-correction decoder on a single CPU and securing an Asia-Pacific hardware deal.
  • Six Flags stock rose pre-market after Jana Partners disclosed a roughly 9% stake and urged the company to explore a sale.
  • SiTime signals a revenue step-up from data-center adoption and a Renesas timing acquisition that adds a near-term $300M kicker.
  • Laureate is pitched as a buy on enrollment growth and buybacks with a roughly $5B market cap.
  • Melco's Morpheus became Macau's first hotel awarded Three MICHELIN Keys, boosting Melco's premium-hospitality profile.

Latest Articles

OmniAb Names New COO; Shares Rise in Premarket Trading

OmniAb Names New COO; Shares Rise in Premarket Trading

OmniAb Inc. announced the creation of a new executive role and the appointment of Amechi Nwachuku as Executive Vice President and Chief Operating Officer. The move, focused on advancing the company's xPloration single B-cell screening platform and commercial strategy, coincided with a 7.6% rise in the stock during premarket trading.

BTIG Names High-Conviction Healthcare Picks for 2H 2026; Mix of Device Makers, Biotech and Services Firms Featured

BTIG Names High-Conviction Healthcare Picks for 2H 2026; Mix of Device Makers, Biotech and Services Firms Featured

BTIG published its Top Picks report for the second half of 2026, identifying a set of healthcare companies it views as high-conviction investments over the next 12 months. The list spans medical device manufacturers, specialty healthcare services firms and clinical-stage biopharma companies that BTIG believes are positioned around regulatory, reimb…

Inter Launches Wearables in the U.S., Taking Banking Beyond the Phone

Inter Launches Wearables in the U.S., Taking Banking Beyond the Phone

Inter has announced the U.S. launch of its wearable payment technology—Inter Ring and Inter Wristband—enabling customers to make secure contactless payments without needing a phone or battery. The wearables operate via passive NFC technology linked to customers’ existing Inter credit cards. Initial availability targets a limited group with a broade…

Coherent Named One of TIME's America's Best Companies 2026

Coherent Named One of TIME's America's Best Companies 2026

Coherent Corp., a global leader in photonics, has been named on TIME's America’s Best Companies 2026 list, based on comprehensive assessments in employee satisfaction, financial performance, and sustainability transparency. This recognition highlights Coherent's strong workforce culture, solid financial metrics, and commitment to ESG standards.

Anixa Biosciences CEO Purchases $15,200 in Shares Amid Clinical Milestones

Anixa Biosciences CEO Purchases $15,200 in Shares Amid Clinical Milestones

Anixa Biosciences CEO Amit Kumar acquired 5,000 shares at $3.04 per share on July 10, 2026, increasing his direct holdings to 635,812 shares. The transaction coincides with the company's clinical trial milestones and the grant of a South Korean patent for its breast cancer vaccine technology. Despite recent progress, the company reported a net loss…

Artelo Biosciences Announces Positive Results with ART27.13 in a Nonclinical Model of Paclitaxel-Induced Peripheral Neuropathy

Artelo Biosciences Announces Positive Results with ART27.13 in a Nonclinical Model of Paclitaxel-Induced Peripheral Neuropathy

Artelo Biosciences announced encouraging nonclinical findings for ART27.13, a peripheral cannabinoid receptor agonist, showing efficacy in reducing paclitaxel-induced neuropathic pain in animal models. This builds on interim Phase 2 CAReS trial results demonstrating improved body weight, lean mass, and activity in cancer patients with anorexia-cach…

Insider Transactions: Major Buys and Sells Reported Friday

Insider Transactions: Major Buys and Sells Reported Friday

Executives and significant shareholders disclosed several large equity purchases and sales across technology, cybersecurity, energy and industrial supply firms. Notable insider buys included large stakes in Netskope Inc, Big Digital Energy, Mission Produce and Gloo Holdings, while big sell-offs were reported at Broadcom, Dell Technologies, Okta, PB…

Power Solutions International Sets Date for Second Quarter 2026 Earnings Release and Conference Call

Power Solutions International Sets Date for Second Quarter 2026 Earnings Release and Conference Call

Power Solutions International, Inc. (NASDAQ: PSIX), a designer and manufacturer of emission-certified engines and power systems, will release its second quarter 2026 earnings on August 6, 2026, followed by a conference call to discuss financial results and business outlook. The company serves diverse markets including power generation, industrial e…

T3 Defense Subsidiary Rimon Delivers $1.1 Million Order with Major Israeli Defense Customer for Advanced Elevated Battlefield Lighting Systems

T3 Defense Subsidiary Rimon Delivers $1.1 Million Order with Major Israeli Defense Customer for Advanced Elevated Battlefield Lighting Systems

T3 Defense's subsidiary Rimon completed the delivery of a $1.1 million order of Yam-Or portable elevated lighting systems to a major Israeli defense customer. The order was fulfilled on schedule and adhered to stringent defense specifications, highlighting Rimon's engineering and manufacturing capabilities for advanced battlefield illumination solu…

Workhorse Appoints Jody Davis as Chief Financial Officer

Workhorse Appoints Jody Davis as Chief Financial Officer

Workhorse Group Inc., a US-based electric vehicle manufacturer specializing in medium-duty trucks, announced the appointment of Jody Davis as its new Chief Financial Officer. Davis brings 15 years of finance leadership experience from sectors including manufacturing and energy storage, and is expected to support Workhorse's transition from developm…

Oncolytics Biotech® Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS-Mutant MSS Colorectal Cancer Trial

Oncolytics Biotech® Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS-Mutant MSS Colorectal Cancer Trial

Oncolytics Biotech reported strong clinical progress and a regulatory milestone for its REO 033 randomized trial evaluating pelareorep in combination with chemotherapy for second-line treatment of RAS-mutant microsatellite stable metastatic colorectal cancer. The company plans a Type D meeting with the FDA to discuss a registrational path by adding…